DD
52
-4
MCD
60
-2
PH
70
-7
ADSK
47
-3
RF
43
-5
MPC
39
-15
MLM
67
-9
FCX
54
-7
PCG
86
-3
TSCO
55
-3
DVN
37
-7
T
41
-4
MNST
61
-4
PLD
43
-5
WMT
62
-5
CHRW
42
-2
LNC
42
-4
NWSA
63
-4
CSX
39
-4
PNC
46
-4
DD
52
-4
MCD
60
-2
PH
70
-7
ADSK
47
-3
RF
43
-5
MPC
39
-15
MLM
67
-9
FCX
54
-7
PCG
86
-3
TSCO
55
-3
DVN
37
-7
T
41
-4
MNST
61
-4
PLD
43
-5
WMT
62
-5
CHRW
42
-2
LNC
42
-4
NWSA
63
-4
CSX
39
-4
PNC
46
-4
Financhill
Back

MoonLake Immunotherapeutics 10K Form

Sell
43

MLTX
MoonLake Immunotherapeutics

Last Price:
42.88
Seasonality Move:
62.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MLTX News And Ratings

See the #1 stock for the next 7 days that we like better than MLTX

MLTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-12.34M
Price / Cash Flow: 0
Annual Sales: $8.20
Price / Book: 5.19

Profitability

EPS (TTM): -0.74000
Net Income (TTM): $-36.01M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

MoonLake Immunotherapeutics Earnings Forecast

Key MoonLake Immunotherapeutics Financial Ratios

  • Per Share Earnings over the last 3 years have been positive in 1 years.

MoonLake Immunotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MLTX
Website: moonlaketx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MLTX Technical Analysis vs Fundamental Analysis

Sell
43
MoonLake Immunotherapeutics (MLTX) is a Sell

Is MoonLake Immunotherapeutics a Buy or a Sell?